Immunotherapy for er+pr+ HER2-
it's wonderful to see that there are trials for triple negative metastatic bc. Are there trials for er+pr+ HER2- happening here at all? I have just returned from the Hallwang Clinic in Germany where...
Forum Discussion
Hi Gierdre
This is Kathy from BCNA's Policy Team.
As some of the ladies here have already mentioned, palbociclib (Ibrance) is a new drug for ER+/PR+/HER2- breast cancer. There have been very good results with it in international trials and it is already available in many countries overseas, including in Europe and the US. We at BCNA hope it will be available in Australia later this year. We are currently writing a submission to the government in support of it, and will publish this on our website when it is finalised. We'll let you know via the online community when it is available for you to read.
It is an oral therapy that is taken with letrozole or faslodex.
There are trials in Australia with palbociclib so you may like to talk to your medical oncologist about whether it would be suitable for you and whether you would be eligible for a trial. There are some pretty strict eligibility criteria.
All the best
Kathy